American Outdoor Brands Third Quarter Fiscal 2025 Financial Release and Conference Call Alert
COLUMBIA, Mo., Feb. 20, 2025 /PRNewswire/ -- American Outdoor Brands, Inc. (NASDAQ Global Select: AOUT), an innovation company that provides product solutions for outdoor enthusiasts, today announced that it plans to release its third quarter fiscal 2025 financial results on Thursday, March 6, 2025, after the close of the market. The full text of the press release will be available on the company's website at www.aob.com under the Investor Relations section.
The company will host a conference call and webcast on Thursday, March 6, 2025, to discuss its third quarter fiscal 2025 financial and operational results. Speakers on the conference call will include Brian Murphy, President and Chief Executive Officer, and Andy Fulmer, Chief Financial Officer. The conference call may include forward-looking statements. The conference call and webcast will begin at 5:00 p.m. Eastern Time (2:00 p.m. Pacific). Those interested in listening to the conference call via telephone may call directly at (844) 481-2551 and ask to join the American Outdoor Brands call. No RSVP is necessary. The conference call audio webcast can also be accessed live on the company's website at www.aob.com, under the Investor Relations section.
About American Outdoor Brands, Inc.American Outdoor Brands, Inc. (NASDAQ Global Select: AOUT) is an innovation company that provides product solutions for outdoor enthusiasts, including hunting, fishing, camping, shooting, outdoor cooking, and personal security and personal defense products. The Company produces innovative, high quality products under brands including BOG®; BUBBA®; Caldwell®; Crimson Trace®; Frankford Arsenal®; Grilla Grills®; Hooyman®; Imperial®; LaserLyte®; Lockdown®; MEAT!™; Old Timer®; Schrade®; Tipton®; Uncle Henry®; ust®; and Wheeler®. For more information about all the brands and products from American Outdoor Brands, Inc., visit aob.com.
Contact: Liz Sharp, VP, Investor Relations lsharp@aob.com (573) 303-4620
View original content to download multimedia:https://www.prnewswire.com/news-releases/american-outdoor-brands-third-quarter-fiscal-2025-financial-release-and-conference-call-alert-302380883.html
SOURCE American Outdoor Brands, Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Green Solvents Market Research 2025-2035: Increasing Applications in Emerging Markets and Industries Driving the Market to Surpass $5.5 Billion by 2035
Growth is seen across diverse applications from paints to pharmaceuticals, though challenges like high costs and limited performance exist. Emerging sectors, regional demand in Asia-Pacific, and competitive innovations boost market potential. Explore trends and opportunities in this comprehensive report. Dublin, June 11, 2025 (GLOBE NEWSWIRE) -- The "Green Solvents Market Research Report 2025-2035" has been added to Green Solvents market accounted for USD 2.2 Billion in 2024 and is expected to reach USD 5.51 Billion by 2035, growing at a CAGR of around 8.7% between 2025 and 2035. The green solvents market is shaped by a growing global emphasis on sustainable industrial processes and environmental conservation. Industries are increasingly moving away from traditional solvents due to their toxicity and harmful environmental impact. Green solvents offer an eco-friendly alternative, helping reduce pollution and health hazards associated with volatile organic the market faces challenges such as higher production costs and the need for extensive research to improve solvent efficiency and applicability. Innovations and regulatory support are pivotal in accelerating adoption. As industries strive for greener operations, the demand for green solvents continues to gain momentum, driving steady transformation in various Government RegulationsGovernments worldwide are enforcing stringent regulations on emissions and chemical usage to protect human health and the environment. These policies limit the use of hazardous solvents, making green solvents a necessary substitute to comply with legal frameworks. Regulatory bodies often incentivize the adoption of sustainable chemicals through subsidies or tax benefits, further motivating industries to switch. Such regulatory pressures not only mitigate environmental damage but also drive innovation in solvent technologies, fostering market growth and Performance in Certain ApplicationsWhile green solvents are eco-friendly, they sometimes lack the broad spectrum of chemical properties offered by traditional solvents. This limits their use in certain industrial applications where high performance or specific chemical characteristics are crucial. In some cases, green solvents may not match the efficacy, solvency power, or stability required, leading companies to hesitate in full adoption. Overcoming this limitation requires ongoing research and development to expand the functionality and performance profile of green into Emerging IndustriesEmerging sectors like bio-based chemicals, pharmaceuticals, and advanced coatings offer promising avenues for green solvent applications. These industries are increasingly adopting sustainable practices, providing fertile ground for green solvent innovation and deployment. As these sectors grow, they present new opportunities for manufacturers to tailor green solvent products to meet specific industry needs, expanding market reach and AnalysisGreen solvents are derived from various renewable sources, including corn, sugarcane, cellulose, and vegetable oils. Bio-based alcohols and esters sourced from crops like corn and sugarcane are widely used due to their abundant availability and low toxicity. Cellulose-derived solvents are gaining traction for their compatibility with high-performance industrial processes. Vegetable oil-based solvents are increasingly preferred in cleaning and lubricant applications for their biodegradability and low environmental choice of source directly influences the solvent's cost, performance, and environmental footprint. As sustainability becomes central to procurement decisions, demand is rising for raw materials that are not only renewable but also sustainably cultivated. The market is gradually witnessing a shift towards sources that offer both environmental and economic solvents are used across a diverse range of applications including paints and coatings, adhesives, pharmaceuticals, personal care products, and industrial cleaners. In paints and coatings, they help reduce VOC emissions and enhance workplace safety. In the pharmaceutical industry, green solvents support safer synthesis and formulation processes with minimal toxic residue. The personal care sector leverages these solvents for their gentle, non-irritating properties in skincare and haircare cleaning applications benefit from their strong solvency and easy biodegradability, ensuring minimal environmental contamination. Adhesives and sealants manufacturers are also increasingly shifting toward green solvents to meet regulatory and consumer demand for non-toxic products. These varied applications demonstrate the versatility and growing integration of green solvents in both consumer and industrial AnalysisAsia-Pacific is experiencing rapid industrial growth alongside increasing regulatory focus on environmental sustainability. The region's expanding manufacturing base and rising environmental concerns create a strong demand for green solvents. Growing awareness and government initiatives to reduce pollution are fostering market development. Additionally, cost advantages and the availability of raw materials support regional production and consumption of green LandscapeThe green solvents market features a mix of global chemical manufacturers and specialized bio-based solvent producers. Leading companies emphasize innovation, sustainability, and expanding product portfolios to capture market share. Collaborations with research institutions and strategic partnerships help drive technological advancements. Companies focus on developing cost-efficient production methods and diversifying applications to meet varied customer needs. Branding efforts highlight environmental benefits and regulatory compliance to strengthen market positioning. Intense competition encourages continuous improvements, benefiting end-users with better solvent options. Key Topics Covered1. Methodology & Report Coverage1.1. Definition & Objective1.2. Market Evaluation & forecast parameter1.3. Research Methodology1.4. Data Validation Sources2. Market Overview3. Green Solvents Market: Market Dynamics3.1. Executive Summary3.2. Market Driving Factors3.2.1. Increasing environmental regulations promoting sustainable practices3.2.2. Rising demand for eco-friendly products across various industries3.2.3. Growing consumer awareness regarding harmful solvent effects3.3. Key industry pitfalls & challenges3.3.1. Higher cost compared to traditional petroleum-based solvents3.3.2. The Limited availability of some bio-based solvents in regions3.3.3. Performance issues in specific applications compared to conventional solvents3.4. Market Opportunities3.4.1. Expansion of bio-based solvent production technologies and innovations3.4.2. Rising interest in green chemistry and sustainable manufacturing3.4.3. Increasing applications in emerging markets and industries3.5. Porter's Five Forces Analysis3.6. PESTLE Analysis3.7. Regulatory landscape3.8. Investment landscape3.9. ESG Scenario3.10. Competitive landscape3.10.1. Company Market Share3.10.2. Market Positioning3.10.3. Strategy framework3.10.4. Recent Acquisitions & Mergers4. Green Solvents Market, Type Segment Analysis4.1. Overview Dynamics4.2. Bio-Alcohols4.3. Bio-Glycols4.4. Bio-Diols4.5. Lactate Esters4.6. D-Limonene4.7. Bio-Based Acetone4.8. Others 5. Green Solvents Market, Source Segment Analysis5.1. Overview5.2. Agricultural Crops5.3. Cellulose & Biomass5.4. Other Renewable Sources 6. Green Solvents Market, Application Segment Analysis6.1. Overview6.2. Paints & Coatings6.3. Adhesives & Sealants6.4. Pharmaceuticals6.5. Cosmetics & Personal Care6.6. Cleaning Products6.7. Printing Inks6.8. Food & Beverages6.9. Other Industrial Applications 7. Green Solvents Market, Region Segment Analysis7.1. Overview7.2. North America7.3. Europe7.4. Asia Pacific7.5. Latin America7.6. MEA 8. Company Profiles8.1. The Dow Chemical Company8.1.1. Business Overview8.1.2. Financial Performance8.1.3. Product/Service Offerings8.1.4. Strategies & recent developments8.1.5. SWOT Analysis8.2. Cargill, Incorporated8.3. Clariant International Ltd.8.4. Bio Brands LLC8.5. Archer Daniels Midland Company8.6. Corbion N.V.8.7. CREMER OLEO GmbH & Co. KG8.8. Vertec BioSolvents Inc.8.9. Florachem Corp.8.10. Solvay SA8.11. Stepan Company8.12. BASF SE8.13. Eastman Chemical Company8.14. GFBiochemicals8.15. Circa Group8.16. India Glycols Limited For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Mattermost Names James Mullins as Vice President of Sales for EMEA and APAC
Proven sales leader brings over 30 years of technology sales experience to drive Mattermost's global growth strategy James Mullins PALO ALTO, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Mattermost, Inc., the trusted leader in secure, real-time collaboration and workflow solutions for defense, intelligence, security, and critical infrastructure, today announced the appointment of James Mullins as Vice President of Sales for Europe, Middle East, Africa (EMEA) and Asia Pacific (APAC) regions. Mullins brings more than three decades of experience in technology sales leadership, with a proven track record of driving global sales growth and developing strategic market initiatives. "James' extensive experience in scaling sales organizations and his deep understanding of international markets make him the ideal leader to expand our presence across EMEA and APAC," said Dave Reardon, CRO at Mattermost. "His expertise in enterprise sales and proven ability to drive growth will be invaluable as we continue to accelerate our global expansion and help more organizations enhance their secure collaboration capabilities." Prior to joining Mattermost, Mullins led the business development function at Ripjar and KYC360, where he successfully implemented sales strategies that drove company growth. Throughout his career, he has held senior sales leadership positions where he has built and led high-performing global sales teams from startup to scale-up phases. "I'm thrilled to join Mattermost at such an exciting time in the company's journey," said Mullins. "The demand for secure, flexible collaboration solutions continues to grow exponentially, particularly among technical teams and organizations with complex security and compliance requirements. I look forward to working with the Mattermost team to expand our global footprint and deliver exceptional value to customers across EMEA and APAC." Mullins has successfully sold into multiple vertical markets including Financial Services, Insurance, Telecommunications, Government, and Oil & Gas. His expertise in driving both sales and market development strategies has consistently delivered strong business results throughout his 30-year career in technology sales. In his new role, Mullins will focus on accelerating Mattermost's growth strategy across EMEA and APAC regions, expanding the company's enterprise customer base, and strengthening strategic partnerships to enhance market presence. About Mattermost Mattermost is the Intelligent Mission Environment that delivers secure chat operations and collaborative workflows for mission-critical work in defense, government, and critical infrastructure. Trusted by the U.S. Department of Defense and Fortune 500s, our open core platform powers focused, adaptable, secure, resilient operations across the most demanding environments. The platform supports Mission Operations, DevSecOps, and Cyber Defense with secure messaging, file sharing, audio calling, screen sharing, workflow automation, and AI assistance—available in self-hosted and on-demand deployments from strategic partners. Built on an open source platform shaped by 4,000+ contributors, Mattermost is co-developed with the world's top security experts to meet the most demanding operational needs. Learn more at Attachment James Mullins CONTACT: Mattermost press@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Energenesis Biomedical to Unveil Promising Parkinson's Disease Therapy, ENERGI-F705PD, at BIO International 2025
TAIPEI, June 11, 2025 /PRNewswire/ -- Energenesis Biomedical Co., Ltd. (TWSE: 6657), a clinical-stage biotechnology company pioneering cellular energy restoration therapeutics, today announced its participation in the BIO International Convention 2025, taking place June 16–19 in Boston, MA. The company will be located at Booth #1645 within the Taiwan Pavilion, to showcase its innovative ENERGI Platform and provide a key update on its investigational Parkinson's disease (PD) therapy, ENERGI-F705PD, a first-in-class treatment with disease-modifying potential. Key Highlights: ENERGI-F705PD is a first-in-class, oral sustained-release therapy in development for Parkinson's disease, designed to address the underlying pathogenesis. Topline data from the Phase I trial in healthy subjects are anticipated in September 2025, following successful completion of recruitment. ENERGI-F705PD aims to combat the root causes of Parkinson's by reducing alpha-synuclein aggregation, enhancing antioxidant capacity, and boosting dopamine synthesis. "We are eager to present the exciting progress of our ENERGI-F705PD program at BIO International 2025," said Dr. Han-Min Chen, CEO of Energenesis Biomedical. "Parkinson's disease remains a challenging condition with significant unmet needs. Our approach focuses on restoring cellular energy and combating critical pathogenesis of PD, offering a potential disease-modifying solution for patients. We look forward to sharing our latest data and exploring potential partnerships that can accelerate the development of this important therapy." About ENERGI-F705PD ENERGI-F705PD is a novel small-molecule drug delivered in an oral sustained-release formulation. It is designed to enhance cellular ATP and antioxidant production by engaging the purine salvage, glycolysis, and pentose phosphate pathways. This multi-pronged mechanism of action directly addresses key pathological hallmarks of Parkinson's disease: Reduce and Prevent α-Synuclein Aggregation: Elevated ATP acts as a hydrotrope, helping prevent the intracellular aggregation of misfolded α-synuclein, a central pathogenic hallmark of PD. Increase Reducing Power (antioxidant): ENERGI-F705PD upregulates the pentose phosphate pathway (PPP), leading to increased NADPH production and enhanced cellular antioxidant defense. Increase Tyrosine Hydroxylase Expression/activity: By optimizing cellular energy metabolism and engaging the purine salvage pathway, ENERGI-F705PD also enhances the expression and activity of tyrosine hydroxylase (TH), the key enzyme in dopamine synthesis, thereby helping restore neurotransmitter levels in the brains of PD patients. About Energenesis Biomedical Energenesis Biomedical Co., Ltd. (TWSE: 6657) is a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics that restore cellular energy and activate intrinsic repair mechanisms. By combining proprietary small-molecule innovation with AI-driven drug repurposing, Energenesis Biomedical aims to accelerate the development of treatments for unmet medical needs across various therapeutic areas, including neurodegenerative diseases, chronic wounds, and rare disorders. The company's robust pipeline includes: ENERGI-F705PD: Oral tablet for Parkinson's disease (Phase I) ENERGI-F703DFU: Gel for Diabetic foot ulcers (Phase III) ENERGI-F701: Tonic for Alopecia (Phase II completed) ENERGI-F703EB: Cream for Epidermolysis bullosa (EB), granted FDA Orphan Drug and Rare Pediatric Disease designation, and EMA orphan designation(Preparing for Phase II) For more information, please visit Contact: Business Development Team Email: partnership@ View original content: SOURCE ENERGENESIS BIOMEDICAL CO., LTD. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
